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Abstract
Background: Effective yet practical strategies are needed to increase engagement in HIV treatment and prevention
services, particularly in high-HIV-prevalence hotspots. We designed a community-based intervention called “Health
Scouts” to promote uptake and adherence to HIV services in a highly HIV-prevalent fishing community in Rakai,
Uganda. Using a situated Information, Motivation, and Behavioral skills theory framework, the intervention consists
of community health workers, called Health Scouts, who use motivational interviewing strategies and mobile health
tools to promote engagement in HIV treatment and prevention services.
Methods/design: The Health Scout intervention is being evaluated through a pragmatic, parallel, cluster-randomized
controlled trial with an allocation ratio of 1:1. The study setting is a single high-HIV-prevalence fishing community in
Rakai, Uganda divided into 40 contiguous neighborhood clusters each containing about 65 households. Twenty
clusters received the Health Scout Intervention; 20 clusters received standard of care. The Health Scout intervention is
delivered within the community at the household level, targeting all residents aged 15 years or older. The primary
programmatic outcomes are self-reported HIV care, antiretroviral therapy, and male circumcision coverage; the primary
biologic outcome is population-level HIV viremia prevalence. Follow-up is planned for about 3 years.
Discussion: HIV treatment and prevention service engagement remains suboptimal in HIV hotspots. New, community-
based implementation approaches are needed. If found to be effective in this trial, the Health Scout intervention may
be an important component of a comprehensive HIV response.
Trial registration: ClinicalTrials.gov, ID: NCT02556957. Registered on 20 September 2015.
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Background
Combination HIV prevention (CHP) is the application of
multiple HIV-prevention interventions, such as antiretro-
viral therapy (ART), and male circumcision (MC), to
maximize population-level impact on HIV incidence [1, 2].
Treatment and prevention service cascades—which depict
engagement and loss of service users and people living
with HIV along the continuum of service delivery—have
fostered skepticism about whether high CHP coverage
goals are realistic [3–5], and highlight the need for effective
and sustainable implementation strategies that are not pri-
marily facility-based [6]. Current studies to evaluate CHP
mostly involve well-resourced approaches, limiting repro-
ducibility and sustainability [7]. Empirical testing of CHP
implementation approaches that are practical and
community-based are, therefore, needed.
HIV hotspots are geographically defined areas of ex-
tremely high HIV transmission and prevalence. Hotspots
are found throughout sub-Saharan Africa (e.g., certain min-
ing and fishing communities), and may compromise na-
tional and regional HIV prevention efforts [8–17]. The
President’s Emergency Plan for AIDS Relief (PEPFAR), the
Joint United National Program on HIV/AIDS (UNAIDS),
and the World Health Organization (WHO) have made
HIV hotspots a central focus of their HIV response [18–20].
However, rigorous evidence on comprehensive and effective
CHP strategies for hotspots is limited and, therefore, a prior-
ity research need [7]. Many Lake Victoria fishing communi-
ties, the setting for this trial, are hotspots due to a number
of factors increasing HIV risk, including high rates of con-
domless sex, multiple sex partners, prominent sex work,
and prevalent alcohol misuse [10, 21].
Fishing communities represent a critical challenge to
HIV prevention in Uganda and the wider region. The fish-
ing community hosting this research has the highest HIV
prevalence, approximately 40%, ever reported from the
Lake Victoria region [21]. It is a place where HIV preven-
tion and service needs are great, yet resources and health
system infrastructure are modest. A community-based ap-
proach offers an opportunity to work with the community
to devise potential solutions to HIV-related challenges.
Successful HIV efforts in this setting may provide a model
for similar settings.
Community health workers (CHWs), using mobile
health technologies (mHealth) and motivational interview-
ing (MI) strategies to tailor intervention messaging, may
represent a high-impact and sustainable CHP implemen-
tation strategy, particularly in HIV hotspots [22–26].
CHW impact could be optimized by mHealth tools as
sub-Saharan Africa has some of the fastest mobile phone
growth rates in the world [27, 28]. CHW effectiveness
could be further enhanced using evidence-based, MI
counseling techniques that emphasize a client-centered
approach. We therefore designed the “Health Scouts”
mLAKE trial (mHealth Lakefolk Actively Keeping En-
gaged) which is a CHW-based, mHealth-supported, MI-
informed, theory-based CHP implementation intervention
being evaluated in an HIV hotspot fishing community in
Rakai, Uganda. MI was chosen as the foundation of the
CHW counseling strategy because of its cross-cultural ro-
bustness, and effectiveness with heterogeneous popula-
tions [29, 30]. HIV hotspots may particularly benefit from
the MI techniques which emphasize taking into consider-
ation complex contextual factors influencing client behav-
iors. mHealth could be of particular benefit in this setting
in assisting CHWs through complicated counseling algo-
rithms for individuals with multiple areas of HIV risk.
Here, we present the study protocol for the mLAKE trial
which began recruitment in September 2015 with follow-
up planned until at least 2018. The objective of the study is
to determine the impact of the CHW intervention on im-
portant HIV-related treatment and prevention outcomes,
i.e,. HIV service uptake and population prevalence of
viremia. This study is being conducted in a hotspot fishing
community because of the need for more effective inter-
ventions to improve treatment and prevention in high-
HIV-burden, high-HIV-risk settings. The protocol format
is guided by the Standard Protocol Items: Recommenda-
tions for Interventional Trials (SPIRIT) Checklist (Add-
itional file 1) and the Consolidated Standards of Reporting




The intervention setting is a fishing community (area
approximately 2 km2, adolescent/adult population ap-
proximately 4400) on Lake Victoria in Rakai District in
south-central Uganda. Rakai District is bordered to the
south by Tanzania and to the east by Lake Victoria. The
fishing community is approximately 235 km from Kampala,
the capital of Uganda. Since 2011, the Rakai Health
Sciences Program (RHSP) has been the primary provider of
CHP services in this fishing community. These services in-
clude community-based demand generation (e.g., mass
media such as radio-talk shows, community meetings, and
drama shows), an HIV clinic which provides free pre-ART
and ART care, community-based HIV testing, and mobile
MC camps. In this community, ART is initiated at time of
diagnosis, irrespective of CD4 count (i.e., test and start
strategy) as fisherfolk have been designated a key popula-
tion by the Ugandan Ministry of Health. The HIV preva-
lence in this community is approximately 40%.
Trial design overview
The impact of the Health Scout intervention will be
assessed through a pragmatic, parallel, cluster-randomized
controlled trial with an allocation ratio of 1:1 and
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superiority framework (Fig. 1). The cluster-randomized
design was chosen over other study designs as individual
and household randomized designs were logistically diffi-
cult to implement and increased contamination risks;
quasi-experimental designs were deemed less rigorous.
Cluster design
The largest of the fishing communities in the region was se-
lected for the mLAKE trial and 40 was chosen as the num-
ber of randomization units. There were several reasons for
choosing 40 units or clusters. First, we anticipated 10
Health Scouts being deployed, each of whom would initially
be allocated the same number of clusters. Some variation in
the type of clusters Health Scouts were assigned was desir-
able to enable more robust analytic inferences on Health
Scout effects. Thus, each Health Scout needed to have at
least two assigned clusters. As progressively larger number
of clusters increased implementation complexity and risk of
contamination, we selected 40 clusters, the minimum num-
ber needed to assign each Health Scout two clusters.
The 40 clusters were then defined with consideration
of implementation logistics, minimizing contamination,
and geographic features such as roads, buildings, and
the lake shoreline. Specifically, high-resolution satellite
images of the community were digitized in ArcGIS 10.3
(ESRI, Redlands, CA, USA). Household GPS locations from
a baseline community census conducted in mid-2015 were
overlaid on the digitized map and the community was di-
vided into 40 contiguous clusters (Fig. 2) each containing
roughly the same number of eligible households and partic-
ipants. Each cluster was estimated, using census data, to
contain approximately 65 households with approximately
1.65 persons aged over 15 years (target population) in each
household or approximately 107 potential eligible clients
per cluster. Community-based participatory walks with the
Health Scouts were conducted to confirm and refine clus-
ter boundaries prior to participant enrollment [33].
Pragmatic design considerations
The study design is pragmatically oriented as our primary
goal is to understand if the Health Scout intervention
works under usual-care conditions. To explicitly describe
the pragmatic characteristics of the trial, we used the
PRECIS-2 tool (Table 1). This tool is a method for scoring
trials on an explanatory to pragmatic continuum across
nine domains. Figure 3 shows a visualization of these
scores via the PRECIS-2 wheel [34].
Study hypotheses
The study hypotheses are that residents in clusters
receiving the Health Scout intervention will have im-
proved HIV service uptake (HIV care, ART, and MC)
and decreased HIV population viremia prevalence (PVP)




The general approach to the design and implementation
of the Health Scout intervention is pragmatically oriented
[34]. That is, a framework for Health Scout recruitment,
training, tasks, quality assurance, and monitoring was de-
veloped, but the intervention is designed with flexibility to
adapt to the needs, constraints, and secular changes
during implementation. The framework included the
following core components: (1) CHW (Health Scout)-
based delivery; (2) counseling using MI strategies; (3)
household-based delivery; and (4) mHealth-support. A
situated Information, Motivation, and Behavioral Skills
(sIMB) theory-based conceptual framework was devel-
oped wherein Health Scouts would promote relevant
tailored information, motivation, and behavioral skills
to improve clients’ engagement in HIV treatment and
prevention services, ultimately leading to improved
HIV-related outcomes, including decreased HIV incidence
(Fig. 4) [35, 36].
Implementation
Ten Health Scouts were recruited from the community
and underwent residential- and field-based training.
Residential training focused on mHealth application/
smartphone use, confidentiality, disclosure, and CHP- and





Health Scout intervention (n=20)
Primary Follow-Up (~32 months)
Fig. 1 The mHealth Lakefolk Actively Keeping Engaged (mLAKE) study flow diagram
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HIV-related knowledge. Field-based training focused
on mock counseling role play, cluster boundary walk-
throughs, and filling out Home Visit Forms. MI skills, a
communication strategy that emphasizes a non-judgmental
and non-confrontational approach to behavior change,
were integrated into Health Scout training. After demon-
strating basic competency with their assigned tasks, Health
Scouts attempted to visit all “clients” (i.e., residents aged
15 years and older, any gender) within their clusters within
3 months of study initiation and follow-up each eligible cli-
ent within their cluster every 3 months for approximately
3 years. During each visit, Health Scouts counsel clients
with assistance from a smartphone application. Visits are
anticipated to take approximately 30–45 min. Each Health
Scout was assigned two clusters containing approximately
215 total eligible clients. Health Scouts were provided com-
pensation for their activities.
Health Scout smartphone application
The Health Scout smartphone application (Fig. 5) func-
tions as a decision and counseling support tool to guide
Health Scouts through the sIMB- informed counseling ses-
sion (emocha Mobile Health Inc., Baltimore, MD, USA).
Using simple forms, the application takes the Health Scout
through three steps: (1) household screening-household
members are screened for age eligibility; (2) individualized
counseling triage – residents who are age-eligible are then
individually asked a series of triage screening questions,
e.g., age, gender, HIV status, to determine which counseling
modules should be activated; and, (3) MI counseling-
tailored counseling modules with MI-informed prompts
and messages are provided for the Health Scout to review
with the client. The application contains nine counseling
modules as shown in Table 2 (Additional file 2). Figure 6
provides a sample schematic of the counseling module
content for a client who knows that they are HIV-positive,
but is not yet in care.
Control arm description
Household residents in both study arms will have access to
standard of care RHSP HIV prevention and treatment ser-
vices as described in the “Study setting” section above.
Health Scouts are not prohibited from interacting with con-
trol arm residents but cannot conduct mHealth-supported
counseling home visits with residents outside of the inter-
vention clusters.
Outcomes
The mLAKE trial has three primary programmatic out-
comes (HIV care, ART, and MC coverage), one primary
biologic outcome (HIV population viremia prevalence
(PVP)), and several secondary outcomes (Table 3). PVP,
variously termed community viral load, population viral
load, or population prevalence of detectable viremia, was
Fig. 2 mHealth Lakefolk Actively Keeping Engaged (mLAKE) trial cluster
map (intervention: clear, control; grayed)
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chosen as the primary biologic outcome because it is
strongly correlated with HIV incidence [37]. The pro-
grammatic outcomes are all key indicators for major
HIV service programs and funders.
Outcome assessment/data collection
Rakai Community Cohort Study (RCCS)
The mLAKE trial is nested within the RCCS which is
conducted by the RHSP. The RCCS is an open,
population-based cohort established in 1994 [38]. The
RCCS currently surveys individuals aged 15–49 years in
40 agrarian, trading, and fishing communities in and
near Rakai District, including the community where
the mLAKE trial is being implemented. For all communi-
ties, the RCCS conducts a census of households with GPS
coordinates recorded and all resident household members
enumerated by gender, age, and duration of residence,
regardless of whether they are present or absent. After
census, the RCCS conducts interviews with consenting
participants to assess demographics, sexual behaviors, and
HIV service uptake. Data are directly entered using
ultra-mobile PCs with pre-coded files and edited in
the field for range and consistency checks to allow
onsite correction of errors. Blood samples are col-
lected for HIV-related tests and HIV viral load assays
of HIV-positive persons. Following the interview, free
HIV testing services using a three-rapid-test algorithm
and post-test counseling are offered to consenting
participants. The RCCS currently conducts its survey
of the trial community approximately every 18 months.
The existing RCCS research infrastructure allows for
efficient assessment of all mLAKE trial outcomes.
Table 1 PRECIS-2 scores for the mHealth Lakefolk Actively Keeping Engaged (mLAKE) trial
Domains Scorea Rationale
Eligibility 5 All residents≥ 15 years of age are eligible for study participation, identical to usual care
Recruitment 4 Recruitment effort (community sensitization, drama shows, and Health Scouts approaching residents) is
likely modestly above what would be expected in usual care
Setting 4 The setting is mostly similar in key characteristics (e.g., high-risk population) to other usual-care settings
Organization 3 The care delivery organization is likely much higher resourced than most usual-care organizations but
efforts were made to replicate more usual-care resource capacity
Flexibility (delivery) 5 Flexibility is anticipated to be the same in how the intervention is delivered in the trial and flexibility
anticipated in usual care
Flexibility (adherence) 5 No special trial measures to promote participant participation with Health Scout intervention
Follow-up 3 Participants being surveyed every at regular intervals in this trial which may be different from other settings
Primary outcome 5 Outcome is very directly relevant to participants
Primary analyses 5 All data will be included in the analysis of the primary outcomes
aPRECIS 5-point Likert Scale, 1 = very explanatory, 2 = rather explanatory, 3 = equally pragmatic/explanatory, 4 = rather pragmatic, 5 = very pragmatic
Fig. 3 PRECIS-2 wheel for the mHealth Lakefolk Actively Keeping Engaged (mLAKE) trial
Chang et al. Trials  (2017) 18:494 Page 5 of 12
Consent (adults)
As this is an additive counseling service being offered only
to community residents randomized to the intervention
arm, consent to receive the counseling service will be ob-
tained orally by the Health Scouts. An oral consent script
will be displayed on the mobile phones. Individuals will be
informed that declining to receive the intervention will in
no way impact their ability to receive usual care and ser-
vices offered through RHSP. Health Scouts are trained to
request consent according to best research practices in a
confidential, non-coercive manner.
Participants in the parent RCCS study will follow the
established written informed consent procedure for
RCCS. The RCCS consent notes potential participation
in nested studies, such as this one, allows for collection
of blood samples, and allows for linking of RCCS
data with available data collected originally for clinical
purposes.
Assent/consent for minors (ages 15–17 years)
Individuals aged 15–17 years will be asked to provide
oral informed assent, and their parents or guardians re-
quested to provide concurrent oral consent. For minors
who are emancipated (e.g., married or living independ-
ently), we will request oral consent from the minor only
per Ugandan guidelines. If assent and consent is ob-
tained as described above, adolescents will be inter-
viewed and counseled in private, without the parent/
guardian being present.
Data monitoring
Primary responsibility for data monitoring will be as-
sumed by a Data Monitoring Committee (DMC) which
will consist of study team members (senior investigators
and primary analyst) without any competing interests.
The DMC will oversee all data sharing, data integrity,
data security, and reporting of analyses of study results.
The DMC will have access to the original study database
and will guide blinded primary data analyses. Study team
members with potential competing interests will not be
members of the DMC and will not have access to the
original study database which will be kept on password-
Information































Contextualizing Factors: Social, Cultural, and Structural
Fig. 4 Health Scout intervention conceptual framework
Fig. 5 Example screenshots from Health Scout smartphone application
Table 2 Health Scout mHealth application counseling modules
# Module description
1 HIV serostatus unknown or no recent HIV test, male or not
pregnant female
2 HIV serostatus unknown or no recent HIV test, pregnant female
3 Male, not circumcised
4 HIV+, not in care
5 HIV+, in care, not on antiretroviral therapy (ART)
6 HIV+, on ART
7 HIV+, pregnant
8 Male having condomless sex
9 Female having condomless sex
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protected servers in Uganda. Access to any data by study
arm and primary study outcomes will not be released
until the data and related analyses have been reviewed
and approved by the DMC.
Access to data
Only DMC members will have access to the original study
database which will be kept on a password-protected ser-
ver in Uganda. Data from this database will be accessible
to other investigators upon request through the DMC.
After trial completion and publication of primary findings,
any data sharing will adhere to established data-sharing
policies of RHSP.
Randomization
Eligibility criteria for clusters and participants
All 40 clusters are eligible for randomization (Fig. 1). All
cluster residents aged 15 years and older are eligible for
participation.
Sequence generation, allocation concealment mechanism,
and implementation
Given the fixed sample size and desire for baseline com-
parability of important characteristics, we used restricted
randomization to allocate intervention arms [39]. First,
we defined a priori that we would accept up to 7.5% dif-
ference in baseline cluster level characteristics (including
percentage of residents aged 20–29 years in the cluster,
percentage of women) and in primary study outcomes
(including cluster level percentage of men circumcised,
percentage of HIV-positive persons in care, percentage
of HIV-positive persons taking ART, percentage HIV
PVP). The 7.5% threshold was chosen for simplicity,
consistency, and face validity. Second, we conducted
2500 independent, simple, computer-generated randomi-
zations, assigning 20 clusters to one arm (coded as 0)
and 20 clusters to a second arm (coded as 1). Third,
among the 2500 randomizations, those who did not
satisfy the above comparability criteria were removed,
resulting in 455 eligible randomizations. Fourth, from
Behavioral Skills
How confident are you that you cold get HIV care if you wanted to?
What are things that would make it difficult to get HIV care
even if you wanted to?
Motivation
What would be some benefits to getting into HIV care?
What are your concerns about it?
What have been the not so good things that have happened
or may happen by not getting into care? Key Messages




















Can you tell me what you know about HIV care?
What concerns do you have about the costs of HIV care?
Intentions
Given how you feel right now, would you want to get HIV care?
Targets
What would need to change for you to want to get HIV care?
Proceed to Other Activated Modules
Fig. 6 Example of counseling module flow and content: HIV-positive, not yet in care
Table 3 Descriptions of mHealth Lakefolk Actively Keeping Engaged (mLAKE) trial primary (1°) and secondary (2°) study outcomesa
Outcome Description Numerator/event Denominator
1° HIV care coverageb Proportion # linked to HIV care # HIV-positive
1° ART coverageb Proportion # on antiretroviral therapy (ART) # HIV-positive
1° MC coverageb Proportion # non-Muslim men circumcised All non-Muslim men aged 15–49 years
1° HIV population viremia prevalence (PVP) Proportion HIV+ c VL > 400 All study participants
2° HIV incidence Rate # new HIV infections HIV-negative person-years
2° HTS coverage Proportion # ever tested and received HIV results All study participants
2° ART treatment failurec Proportion Composite: virologic failure or Mortality or lost to
follow-up or stopped ART
# initiated on ART
2° Consistent condom useb Proportion # using condoms consistently past 12 months # sexually active
aOutcomes described at the cluster level; outcomes may also be analyzed at the individual level
bSelf-reported
cOutcomes will also be individually analyzed. Virologic failure = any viral load (VL) > 1000 copies/mL. Lost to follow-up = no clinic visit > 180 days
ART antiretroviral therapy, HTS HIV Testing Services, MC male circumcision
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the 455 randomizations, one randomization sequence
was randomly drawn for allocation of intervention. Final
assignment of arms (0 and 1) to intervention and control
was done in a public coin-flip ceremony witnessed by
study staff and the Health Scouts.
Blinding
By nature of the intervention, Health Scouts and partici-
pants will not be blinded to intervention assignment.
The RCCS study team members assessing outcomes, in-
cluding the primary analyst, will be blinded to interven-
tion assignment.
Sample size/power
The sample size for this trial is fixed. Therefore, the rele-
vant study power-related question was to estimate whether
the trial had reasonable chance to detect public health-
relevant differences in primary study outcomes, i.e., mini-
mum detectable differences (MDD). Baseline data from a
mid-2015 RCCS survey of the fishing community were
used to first estimate the coefficients of variation (CV) or
intracluster correlation coefficients (ICC) (Table 4). We
then used prior data from 9–10/2013 (approximately
18 months prior to the mid-2015 data) to project the ex-
pected prevalence of the primary outcomes expected for
the control arm at the end of the trial (Table 4). The
mLAKE trial is planned for approximately 36 months of
follow-up, i.e., two RCCS rounds after the baseline 2015
round. The assumption is that 2013 through 2015 were
times of rapid scale-up of CHP service access and that this
momentum will slow (roughly by 50% for MC, HIV care
and by 75% for PVP, ART, and HIV incidence) over the
next 36 months.
MDDs were subsequently calculated with 80% power as
described by Hayes and Moulton (Table 5) [39]. Potential
impact of contamination was also assessed by assuming
10–50% of control arm residents would be influenced by
the intervention. Based upon these calculations, the study
should have MDD ratios with 80% power to be able to de-
tect a 41% or greater decrease in PVP, 15% or greater in-
crease in HIV care coverage, 20% or greater increase in
ART coverage, and 23% or greater increase in MC cover-
age. Study power was considered reasonable by the study
team for all primary outcomes.
Participant timeline
Participants were recruited beginning September 2015.
As shown in the SPIRIT Figure (Fig. 7), participants will
be recruited in an ongoing fashion and followed for two
rounds of RCCS or approximately 36 months (usually
approximately 18 months between rounds). In-migrating
participants can be recruited at any time they are en-
countered by Health Scouts in an intervention cluster
during the study period. Participants can also out-
migrate or decline participation at any point in time.
Process and qualitative evaluations will be conducted
during and after the follow-up period. A cost analysis is
planned after trial completion.
Participant recruitment
mLAKE trial-specific recruitment began with a
community-wide sensitization in which community
leaders along with RHSP staff informed the community
about the mLAKE trial. They explained the randomized
nature of the study using locally appropriate examples.
This process had been successfully implemented in
previous randomized trials and resulted in excellent
community support for RHSP research [40]. When the
Health Scouts were subsequently deployed, they began
recruiting community residents to receive the counseling
service as described above. Recruitment for the RCCS
will follow usual procedures [21].
Statistical methods
The comparability of intervention and control arms will
be assessed at baseline. Two-sample t tests will be used to
compare the baseline cluster-level outcomes (individual-
level data at baseline are not available for participants ab-
sent from the baseline survey). Additionally, participant
demographics (age, sex) are known risk factors for the
study outcomes, and will be assessed for comparability. If
a baseline outcome or demographic variable are signifi-
cantly different between arms with p value ≤ 0.1, adjusted
regression analysis on the outcome variables will be con-
ducted adjusting for baseline covariates.
The cluster-level data for study outcomes will be pre-
sented by survey and by arm. The primary analysis will be
by intent-to-treat and use generalized linear models (GLM)
with generalized estimating equation (GEE) to account for
Table 4 Power calculation parameters and derivation of control arm outcome estimates at the end of the trial
Characteristics CV ICC 2013 2015 2013 to 2015 Δ Proposed control arm outcome
Population viremia prevalence (PVP) 0.33 0.02 25% 16% 9% 11.2%
HIV care coverage 0.141 0.061 70% 75% 4.8% 80.1%
ART coverage 0.187 0.072 43% 67% 24.6% 79.7%
MC coverage 0.209 0.062 52% 59% 8.1% 66.9%
HIV incidence 0.929 NA 3.34 2.9 0.44 2.7
ART antiretroviral therapy, MC male circumcision, NA not applicable
Chang et al. Trials  (2017) 18:494 Page 8 of 12
within-cluster correlations. Specifically, the logistic model
with GEE will be used for binary outcomes (e.g., PVP, MC,
ART), and Poisson log-linear model with GEE will be used
for the HIV-incidence outcome. Exchangeable correlation
structure will be used in the GEE models. Separate analysis
will be conducted for each RCCS follow-up survey to as-
sess the shorter- and longer-term effect of the intervention.
Study monitoring
We will continuously monitor study implementation by
analyzing process data. These data may be used to
adapt/reinforce the pragmatic Health Scout intervention,
e.g., retraining on certain aspects of MI. All modifications
will be documented in detail. A questionnaire module will
be developed and affixed to the RCCS survey to assess
participants’ knowledge, attitudes, and interaction with
the intervention. These data will help determine interven-
tion fidelity and reach, and will allow assessment of the
magnitude of any contamination.
Harms
Potential harms and adverse events will be routinely mon-
itored and reported by study staff and the principal inves-
tigator according to NIH guidelines. Staff will be trained
to complete an Adverse Event Form or a Protocol Viola-
tion Form that will be filed and electronically sent to the
principal investigator for review. The principal investigator
will ensure that study staff are appropriately trained on
Table 5 Calculation of minimum detectable difference (MDD) for the mHealth Lakefolk Actively Keeping Engaged (mLAKE) trial




MDD ratio MDD difference
PVP 0.112 0 0.112 0.066 0.593 −0.046
PVP 0.112 0.1 0.107 0.063 0.559 −0.049
PVP 0.112 0.2 0.101 0.059 0.524 −0.053
PVP 0.112 0.3 0.095 0.054 0.482 −0.058
PVP 0.112 0.4 0.087 0.048 0.433 −0.064
PVP 0.112 0.5 0.077 0.041 0.37 −0.071
HIV care coverage 0.801 0 0.801 0.92 1.149 0.119
HIV care coverage 0.801 0.1 0.814 0.934 1.147 0.12
HIV care coverage 0.801 0.2 0.831 0.952 1.145 0.121
HIV care coverage 0.801 0.3 0.854 0.976 1.144 0.122
HIV care coverage 0.801 0.4 NA NA NA NA
HIV care coverage 0.801 0.5 NA NA NA NA
ART coverage 0.797 0 0.797 0.952 1.195 0.155
ART coverage 0.797 0.1 0.814 0.971 1.193 0.157
ART coverage 0.797 0.2 0.837 0.997 1.191 0.16
ART coverage 0.797 0.3 NA NA NA NA
ART coverage 0.797 0.4 NA NA NA NA
ART coverage 0.797 0.5 NA NA NA NA
MC coverage 0.669 0 0.669 0.822 1.229 0.153
MC coverage 0.669 0.1 0.686 0.842 1.227 0.156
MC coverage 0.669 0.2 0.709 0.869 1.225 0.16
MC coverage 0.669 0.3 0.739 0.904 1.222 0.164
MC coverage 0.669 0.4 0.783 0.955 1.219 0.172
MC coverage 0.669 0.5 NA NA NA NA
HIV incidence 0.027 0 0.027 0.005 0.201 −0.021
HIV incidence 0.027 0.1 0.025 0.005 0.176 −0.022
HIV incidence 0.027 0.2 0.022 0.004 0.146 −0.023
HIV incidence 0.027 0.3 0.02 0.003 0.116 −0.024
HIV incidence 0.027 0.4 0.017 0.002 0.08 −0.025
HIV incidence 0.027 0.5 0.014 0.001 0.05 −0.025
ART antiretroviral therapy, MC male circumcision, NA not applicable, PVP population viremia prevalence
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adverse event reporting. Severe adverse events (e.g., breach
of confidential information) will be reported promptly to
the appropriate Institutional Review Boards (IRBs).
Auditing
The study principal investigator (LC) will have primary
responsibility for monitoring study conduct and partici-
pant safety. LC will make about biannual audit visits to
the study site and conduct reviews of study materials
(e.g., completion of Consent Forms, log books, Adverse
Event Forms) and procedures.
Confidentiality
Confidentially will be promoted by focused training on
this topic with all Health Scouts and study staff. Health
Scouts will be trained to make all possible efforts to en-
sure privacy during Health Scout and participant inter-
actions. Participants may also elect to be contacted on
their phone rather than to meet in person if they feel
more comfortable with this mode of interaction or to
meet in a place outside their home for follow-up visits.
Some study data will be collected from mobile phones,
including GPS location data of residences. No names
will be collected on the phones. All phones used to col-
lect these data will be password protected and all data
stored on the phones will be encrypted. Phones will be
wiped clean of data after final data transfer. Data collected
on the phones will be transferred to a secure server using
the local cellular network or Wi-Fi. All data transfers will
be done in a secure fashion using state-of-the-art encryp-
tion techniques. Data stored on the server will also be
encrypted, password protected, and only made available to
the relevant study team members. All geospatial data will
be protected to avoid identifying participant information.
In all visual presentations of this type of data, specific loca-
tions will be “blurred” or presented in an aggregate format
so that individual-level identification of characteristics will
not be possible. If a phone is lost or stolen, data will remain
secure on the device as it will be encrypted, password pro-
tected, and can be remotely wiped.
Protocol amendments
Important protocol modifications (e.g., changes to eligibility
criteria, outcomes, etc.) will be reported to all IRBs and fun-
ders according to their usual procedures. Trial registries will
also be notified and updated as appropriate. Major protocol
changes will be reported in any subsequent publications.
Ancillary and post-trial care
If the intervention is found to be effective and afford-
able, we will attempt to secure resources to provide the
intervention for all study participants.
STUDY PERIOD
Enrolment Allocation Post-allocation Close-out


















Fig. 7 SPIRIT Figure; the mHealth Lakefolk Actively Keeping Engaged (mLAKE) trial schedule of enrollment, interventions, and assessments
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Dissemination policy
Study protocol and results will be presented at scientific
conferences and in peer-reviewed publications. The roles
of authors will be disclosed. Authorship eligibility follows
the common standards of author responsibility, conflict of
interest, transparency and the recommendations of the
International Committee of Medical Journal Editors.
Discussion
HIV treatment and prevention service engagement re-
mains suboptimal, particularly in HIV hotspots in sub-
Saharan Africa. New, community-based implementation
approaches which are evidence-based are needed. The
mLAKE trial seeks to assess the impact of the Health
Scout intervention in a pragmatic trial as one strategy
for improving CHP implementation.
The Health Scout intervention has several notable features.
The Health Scout intervention is theory-based, using the
sIMB model for care engagement, providing grounding for
its application and evaluation [35]. It incorporates a motiv-
ational interviewing approach which has only been used in a
small number of programs in sub-Saharan Africa despite evi-
dence on its effectiveness in other settings [30, 41–43]. The
intervention also incorporates a novel mHealth application
which acts as a counseling and decision support tool. The
application is intentionally built to be user-friendly and scal-
able in similar resource-limited settings.
The design of this trial has some noteworthy charac-
teristics. The cluster design is unusual as typically clus-
ters are more geographically separate [39]. However, the
chosen cluster design was a pragmatic decision to allow
a reasonable design for obtaining rigorous data on inter-
vention impact. Close monitoring and reporting of inter-
vention reach and control arm contamination will be
critical to assessing the validity of study results. Addition-
ally, the nature of the Health Scout intervention is com-
plex and pragmatic. Secular and deliberate changes to the
intervention, participants, and setting may occur over the
course of the follow-up period. Thus, the planned process
and mixed-methods evaluations will be helpful in provid-
ing a more comprehensive assessment of the implementa-
tion and impact of the intervention [44].
This study has a number of potential limitations. Con-
tamination of control clusters may decrease study power
to detect any true intervention effects. Secular changes,
such as greater than anticipated scale-up of CHP services
in control arms, may also decrease study power. Finally,
findings from this study may not be easily generalizable
outside of this particular HIV hotspot setting.
In summary, the mLAKE trial seeks to test the impact of
the Health Scout intervention on CHP implementation. If
found to be effective in this cluster-randomized trial, the
Health Scout intervention may be an important strategy as
part of a comprehensive and effective HIV response.
Trial status
The trial started recruitment in September 2015. Re-
cruitment is ongoing and is expected to be completed by
December 2018.
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